カテゴリー： LP Information, 世界, 部品/材料

世界の医薬品用ベタイン市場予測 2023年-2029年

◆英語タイトル：Global Betaine for Pharmaceutical Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU6046）◆商品コード：LP23JU6046
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の医薬品用ベタイン市場」は、過去の販売実績から2022年の世界の医薬品用ベタインの総販売量を検討し、2023年から2029年の予測される医薬品用ベタインの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医薬品用ベタインの市場規模を掲載し、XXX百万米ドル規模の世界の医薬品用ベタイン市場の詳細な分析を提供します。本インサイトレポートは、世界の医薬品用ベタイン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の医薬品用ベタイン市場における各社の独自のポジションをより深く理解するために、医薬品用ベタイン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の医薬品用ベタイン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医薬品用ベタインの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医薬品用ベタインの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医薬品用ベタインのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

医薬品用ベタインの世界主要メーカーとしては、DuPont、 Evonik、 Agrana、 Asahi Kasei、 Healthy-tech、 Shandong Ruihong、 SUNWIN、 Jujia Group、 Sdefine、 Pengbo Biotechnologyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医薬品用ベタイン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では医薬品用ベタイン市場をセグメンテーションし、種類別 (天然ベタイン、合成ベタイン)、用途別 (医薬品、栄養補助食品、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：天然ベタイン、合成ベタイン

・用途別区分：医薬品、栄養補助食品、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の医薬品用ベタイン市場の10年間の市場状況・展望は？
・世界および地域別に見た医薬品用ベタイン市場成長の要因は何か？
・医薬品用ベタインの市場機会はエンドマーケットの規模によってどのように変化するのか？
・医薬品用ベタインのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：医薬品用ベタインの年間販売量2018-2029、地域別現状・将来分析
・医薬品用ベタインの種類別セグメント：天然ベタイン、合成ベタイン
・医薬品用ベタインの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・医薬品用ベタインの用途別セグメント：医薬品、栄養補助食品、その他
・医薬品用ベタインの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の医薬品用ベタイン市場
・企業別のグローバル医薬品用ベタイン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の医薬品用ベタインの年間売上：2018-2023年の売上、市場シェア
・企業別の医薬品用ベタイン販売価格
・主要企業の医薬品用ベタイン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

医薬品用ベタインの地域別レビュー
・地域別の医薬品用ベタイン市場規模2018-2023：年間販売量、売上
・主要国別の医薬品用ベタイン市場規模2018-2023：年間販売量、売上
・南北アメリカの医薬品用ベタイン販売の成長
・アジア太平洋の医薬品用ベタイン販売の成長
・ヨーロッパの医薬品用ベタイン販売の成長
・中東・アフリカの医薬品用ベタイン販売の成長

南北アメリカ市場
・南北アメリカの国別の医薬品用ベタイン販売量、売上（2018-2023）
・南北アメリカの医薬品用ベタインの種類別販売量
・南北アメリカの医薬品用ベタインの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の医薬品用ベタイン販売量、売上（2018-2023）
・アジア太平洋の医薬品用ベタインの種類別販売量
・アジア太平洋の医薬品用ベタインの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の医薬品用ベタイン販売量、売上（2018-2023）
・ヨーロッパの医薬品用ベタインの種類別販売量
・ヨーロッパの医薬品用ベタインの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の医薬品用ベタイン販売量、売上（2018-2023）
・中東・アフリカの医薬品用ベタインの種類別販売量
・中東・アフリカの医薬品用ベタインの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・医薬品用ベタインの製造コスト構造分析
・医薬品用ベタインの製造プロセス分析
・医薬品用ベタインの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・医薬品用ベタインの主要なグローバル販売業者
・医薬品用ベタインの主要なグローバル顧客

地域別の医薬品用ベタイン市場予測レビュー
・地域別の医薬品用ベタイン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・医薬品用ベタインの種類別市場規模予測
・医薬品用ベタインの用途別市場規模予測

主要企業分析
DuPont、 Evonik、 Agrana、 Asahi Kasei、 Healthy-tech、 Shandong Ruihong、 SUNWIN、 Jujia Group、 Sdefine、 Pengbo Biotechnology
・企業情報
・医薬品用ベタイン製品
・医薬品用ベタイン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

In medicine, betaine can be used to produce medicines, antibiotics, and vitamins for the treatment and prevention of liver diseases. Betaine can also be used to treat human homocysteinuria and prevent fatty liver. Long-term application has no adverse reactions.
LPI (LP Information)’ newest research report, the “Betaine for Pharmaceutical Industry Forecast” looks at past sales and reviews total world Betaine for Pharmaceutical sales in 2022, providing a comprehensive analysis by region and market sector of projected Betaine for Pharmaceutical sales for 2023 through 2029. With Betaine for Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Betaine for Pharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Betaine for Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Betaine for Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Betaine for Pharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Betaine for Pharmaceutical and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Betaine for Pharmaceutical.
The global Betaine for Pharmaceutical market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Betaine for Pharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Betaine for Pharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Betaine for Pharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Betaine for Pharmaceutical players cover DuPont, Evonik, Agrana, Asahi Kasei, Healthy-tech, Shandong Ruihong, SUNWIN, Jujia Group and Sdefine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Betaine for Pharmaceutical market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Natural Betaine
Synthetic Betaine
Segmentation by application
Pharmaceutical
Dietary Supplements
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
DuPont
Evonik
Agrana
Asahi Kasei
Healthy-tech
Shandong Ruihong
SUNWIN
Jujia Group
Sdefine
Pengbo Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Betaine for Pharmaceutical market?
What factors are driving Betaine for Pharmaceutical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Betaine for Pharmaceutical market opportunities vary by end market size?
How does Betaine for Pharmaceutical break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Betaine for Pharmaceutical Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Betaine for Pharmaceutical by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Betaine for Pharmaceutical by Country/Region, 2018, 2022 & 2029
2.2 Betaine for Pharmaceutical Segment by Type
2.2.1 Natural Betaine
2.2.2 Synthetic Betaine
2.3 Betaine for Pharmaceutical Sales by Type
2.3.1 Global Betaine for Pharmaceutical Sales Market Share by Type (2018-2023)
2.3.2 Global Betaine for Pharmaceutical Revenue and Market Share by Type (2018-2023)
2.3.3 Global Betaine for Pharmaceutical Sale Price by Type (2018-2023)
2.4 Betaine for Pharmaceutical Segment by Application
2.4.1 Pharmaceutical
2.4.2 Dietary Supplements
2.4.3 Others
2.5 Betaine for Pharmaceutical Sales by Application
2.5.1 Global Betaine for Pharmaceutical Sale Market Share by Application (2018-2023)
2.5.2 Global Betaine for Pharmaceutical Revenue and Market Share by Application (2018-2023)
2.5.3 Global Betaine for Pharmaceutical Sale Price by Application (2018-2023)
3 Global Betaine for Pharmaceutical by Company
3.1 Global Betaine for Pharmaceutical Breakdown Data by Company
3.1.1 Global Betaine for Pharmaceutical Annual Sales by Company (2018-2023)
3.1.2 Global Betaine for Pharmaceutical Sales Market Share by Company (2018-2023)
3.2 Global Betaine for Pharmaceutical Annual Revenue by Company (2018-2023)
3.2.1 Global Betaine for Pharmaceutical Revenue by Company (2018-2023)
3.2.2 Global Betaine for Pharmaceutical Revenue Market Share by Company (2018-2023)
3.3 Global Betaine for Pharmaceutical Sale Price by Company
3.4 Key Manufacturers Betaine for Pharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Betaine for Pharmaceutical Product Location Distribution
3.4.2 Players Betaine for Pharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Betaine for Pharmaceutical by Geographic Region
4.1 World Historic Betaine for Pharmaceutical Market Size by Geographic Region (2018-2023)
4.1.1 Global Betaine for Pharmaceutical Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Betaine for Pharmaceutical Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Betaine for Pharmaceutical Market Size by Country/Region (2018-2023)
4.2.1 Global Betaine for Pharmaceutical Annual Sales by Country/Region (2018-2023)
4.2.2 Global Betaine for Pharmaceutical Annual Revenue by Country/Region (2018-2023)
4.3 Americas Betaine for Pharmaceutical Sales Growth
4.4 APAC Betaine for Pharmaceutical Sales Growth
4.5 Europe Betaine for Pharmaceutical Sales Growth
4.6 Middle East & Africa Betaine for Pharmaceutical Sales Growth
5 Americas
5.1 Americas Betaine for Pharmaceutical Sales by Country
5.1.1 Americas Betaine for Pharmaceutical Sales by Country (2018-2023)
5.1.2 Americas Betaine for Pharmaceutical Revenue by Country (2018-2023)
5.2 Americas Betaine for Pharmaceutical Sales by Type
5.3 Americas Betaine for Pharmaceutical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Betaine for Pharmaceutical Sales by Region
6.1.1 APAC Betaine for Pharmaceutical Sales by Region (2018-2023)
6.1.2 APAC Betaine for Pharmaceutical Revenue by Region (2018-2023)
6.2 APAC Betaine for Pharmaceutical Sales by Type
6.3 APAC Betaine for Pharmaceutical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Betaine for Pharmaceutical by Country
7.1.1 Europe Betaine for Pharmaceutical Sales by Country (2018-2023)
7.1.2 Europe Betaine for Pharmaceutical Revenue by Country (2018-2023)
7.2 Europe Betaine for Pharmaceutical Sales by Type
7.3 Europe Betaine for Pharmaceutical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Betaine for Pharmaceutical by Country
8.1.1 Middle East & Africa Betaine for Pharmaceutical Sales by Country (2018-2023)
8.1.2 Middle East & Africa Betaine for Pharmaceutical Revenue by Country (2018-2023)
8.2 Middle East & Africa Betaine for Pharmaceutical Sales by Type
8.3 Middle East & Africa Betaine for Pharmaceutical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Betaine for Pharmaceutical
10.3 Manufacturing Process Analysis of Betaine for Pharmaceutical
10.4 Industry Chain Structure of Betaine for Pharmaceutical
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Betaine for Pharmaceutical Distributors
11.3 Betaine for Pharmaceutical Customer
12 World Forecast Review for Betaine for Pharmaceutical by Geographic Region
12.1 Global Betaine for Pharmaceutical Market Size Forecast by Region
12.1.1 Global Betaine for Pharmaceutical Forecast by Region (2024-2029)
12.1.2 Global Betaine for Pharmaceutical Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Betaine for Pharmaceutical Forecast by Type
12.7 Global Betaine for Pharmaceutical Forecast by Application
13 Key Players Analysis
13.1 DuPont
13.1.1 DuPont Company Information
13.1.2 DuPont Betaine for Pharmaceutical Product Portfolios and Specifications
13.1.3 DuPont Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 DuPont Main Business Overview
13.1.5 DuPont Latest Developments
13.2 Evonik
13.2.1 Evonik Company Information
13.2.2 Evonik Betaine for Pharmaceutical Product Portfolios and Specifications
13.2.3 Evonik Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Evonik Main Business Overview
13.2.5 Evonik Latest Developments
13.3 Agrana
13.3.1 Agrana Company Information
13.3.2 Agrana Betaine for Pharmaceutical Product Portfolios and Specifications
13.3.3 Agrana Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Agrana Main Business Overview
13.3.5 Agrana Latest Developments
13.4 Asahi Kasei
13.4.1 Asahi Kasei Company Information
13.4.2 Asahi Kasei Betaine for Pharmaceutical Product Portfolios and Specifications
13.4.3 Asahi Kasei Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Asahi Kasei Main Business Overview
13.4.5 Asahi Kasei Latest Developments
13.5 Healthy-tech
13.5.1 Healthy-tech Company Information
13.5.2 Healthy-tech Betaine for Pharmaceutical Product Portfolios and Specifications
13.5.3 Healthy-tech Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Healthy-tech Main Business Overview
13.5.5 Healthy-tech Latest Developments
13.6 Shandong Ruihong
13.6.1 Shandong Ruihong Company Information
13.6.2 Shandong Ruihong Betaine for Pharmaceutical Product Portfolios and Specifications
13.6.3 Shandong Ruihong Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shandong Ruihong Main Business Overview
13.6.5 Shandong Ruihong Latest Developments
13.7 SUNWIN
13.7.1 SUNWIN Company Information
13.7.2 SUNWIN Betaine for Pharmaceutical Product Portfolios and Specifications
13.7.3 SUNWIN Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 SUNWIN Main Business Overview
13.7.5 SUNWIN Latest Developments
13.8 Jujia Group
13.8.1 Jujia Group Company Information
13.8.2 Jujia Group Betaine for Pharmaceutical Product Portfolios and Specifications
13.8.3 Jujia Group Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jujia Group Main Business Overview
13.8.5 Jujia Group Latest Developments
13.9 Sdefine
13.9.1 Sdefine Company Information
13.9.2 Sdefine Betaine for Pharmaceutical Product Portfolios and Specifications
13.9.3 Sdefine Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sdefine Main Business Overview
13.9.5 Sdefine Latest Developments
13.10 Pengbo Biotechnology
13.10.1 Pengbo Biotechnology Company Information
13.10.2 Pengbo Biotechnology Betaine for Pharmaceutical Product Portfolios and Specifications
13.10.3 Pengbo Biotechnology Betaine for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Pengbo Biotechnology Main Business Overview
13.10.5 Pengbo Biotechnology Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Betaine for Pharmaceutical Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Betaine for Pharmaceutical Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Natural Betaine
Table 4. Major Players of Synthetic Betaine
Table 5. Global Betaine for Pharmaceutical Sales by Type (2018-2023) & (Tons)
Table 6. Global Betaine for Pharmaceutical Sales Market Share by Type (2018-2023)
Table 7. Global Betaine for Pharmaceutical Revenue by Type (2018-2023) & ($ million)
Table 8. Global Betaine for Pharmaceutical Revenue Market Share by Type (2018-2023)
Table 9. Global Betaine for Pharmaceutical Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Betaine for Pharmaceutical Sales by Application (2018-2023) & (Tons)
Table 11. Global Betaine for Pharmaceutical Sales Market Share by Application (2018-2023)
Table 12. Global Betaine for Pharmaceutical Revenue by Application (2018-2023)
Table 13. Global Betaine for Pharmaceutical Revenue Market Share by Application (2018-2023)
Table 14. Global Betaine for Pharmaceutical Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Betaine for Pharmaceutical Sales by Company (2018-2023) & (Tons)
Table 16. Global Betaine for Pharmaceutical Sales Market Share by Company (2018-2023)
Table 17. Global Betaine for Pharmaceutical Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Betaine for Pharmaceutical Revenue Market Share by Company (2018-2023)
Table 19. Global Betaine for Pharmaceutical Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Betaine for Pharmaceutical Producing Area Distribution and Sales Area
Table 21. Players Betaine for Pharmaceutical Products Offered
Table 22. Betaine for Pharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Betaine for Pharmaceutical Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Betaine for Pharmaceutical Sales Market Share Geographic Region (2018-2023)
Table 27. Global Betaine for Pharmaceutical Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Betaine for Pharmaceutical Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Betaine for Pharmaceutical Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Betaine for Pharmaceutical Sales Market Share by Country/Region (2018-2023)
Table 31. Global Betaine for Pharmaceutical Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Betaine for Pharmaceutical Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Betaine for Pharmaceutical Sales by Country (2018-2023) & (Tons)
Table 34. Americas Betaine for Pharmaceutical Sales Market Share by Country (2018-2023)
Table 35. Americas Betaine for Pharmaceutical Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Betaine for Pharmaceutical Revenue Market Share by Country (2018-2023)
Table 37. Americas Betaine for Pharmaceutical Sales by Type (2018-2023) & (Tons)
Table 38. Americas Betaine for Pharmaceutical Sales by Application (2018-2023) & (Tons)
Table 39. APAC Betaine for Pharmaceutical Sales by Region (2018-2023) & (Tons)
Table 40. APAC Betaine for Pharmaceutical Sales Market Share by Region (2018-2023)
Table 41. APAC Betaine for Pharmaceutical Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Betaine for Pharmaceutical Revenue Market Share by Region (2018-2023)
Table 43. APAC Betaine for Pharmaceutical Sales by Type (2018-2023) & (Tons)
Table 44. APAC Betaine for Pharmaceutical Sales by Application (2018-2023) & (Tons)
Table 45. Europe Betaine for Pharmaceutical Sales by Country (2018-2023) & (Tons)
Table 46. Europe Betaine for Pharmaceutical Sales Market Share by Country (2018-2023)
Table 47. Europe Betaine for Pharmaceutical Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Betaine for Pharmaceutical Revenue Market Share by Country (2018-2023)
Table 49. Europe Betaine for Pharmaceutical Sales by Type (2018-2023) & (Tons)
Table 50. Europe Betaine for Pharmaceutical Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Betaine for Pharmaceutical Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Betaine for Pharmaceutical Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Betaine for Pharmaceutical Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Betaine for Pharmaceutical Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Betaine for Pharmaceutical Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Betaine for Pharmaceutical Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Betaine for Pharmaceutical
Table 58. Key Market Challenges & Risks of Betaine for Pharmaceutical
Table 59. Key Industry Trends of Betaine for Pharmaceutical
Table 60. Betaine for Pharmaceutical Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Betaine for Pharmaceutical Distributors List
Table 63. Betaine for Pharmaceutical Customer List
Table 64. Global Betaine for Pharmaceutical Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Betaine for Pharmaceutical Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Betaine for Pharmaceutical Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Betaine for Pharmaceutical Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Betaine for Pharmaceutical Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Betaine for Pharmaceutical Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Betaine for Pharmaceutical Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Betaine for Pharmaceutical Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Betaine for Pharmaceutical Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Betaine for Pharmaceutical Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Betaine for Pharmaceutical Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Betaine for Pharmaceutical Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Betaine for Pharmaceutical Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Betaine for Pharmaceutical Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. DuPont Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 79. DuPont Betaine for Pharmaceutical Product Portfolios and Specifications
Table 80. DuPont Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. DuPont Main Business
Table 82. DuPont Latest Developments
Table 83. Evonik Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 84. Evonik Betaine for Pharmaceutical Product Portfolios and Specifications
Table 85. Evonik Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Evonik Main Business
Table 87. Evonik Latest Developments
Table 88. Agrana Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 89. Agrana Betaine for Pharmaceutical Product Portfolios and Specifications
Table 90. Agrana Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Agrana Main Business
Table 92. Agrana Latest Developments
Table 93. Asahi Kasei Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 94. Asahi Kasei Betaine for Pharmaceutical Product Portfolios and Specifications
Table 95. Asahi Kasei Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Asahi Kasei Main Business
Table 97. Asahi Kasei Latest Developments
Table 98. Healthy-tech Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 99. Healthy-tech Betaine for Pharmaceutical Product Portfolios and Specifications
Table 100. Healthy-tech Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Healthy-tech Main Business
Table 102. Healthy-tech Latest Developments
Table 103. Shandong Ruihong Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 104. Shandong Ruihong Betaine for Pharmaceutical Product Portfolios and Specifications
Table 105. Shandong Ruihong Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Shandong Ruihong Main Business
Table 107. Shandong Ruihong Latest Developments
Table 108. SUNWIN Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 109. SUNWIN Betaine for Pharmaceutical Product Portfolios and Specifications
Table 110. SUNWIN Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. SUNWIN Main Business
Table 112. SUNWIN Latest Developments
Table 113. Jujia Group Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 114. Jujia Group Betaine for Pharmaceutical Product Portfolios and Specifications
Table 115. Jujia Group Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Jujia Group Main Business
Table 117. Jujia Group Latest Developments
Table 118. Sdefine Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 119. Sdefine Betaine for Pharmaceutical Product Portfolios and Specifications
Table 120. Sdefine Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Sdefine Main Business
Table 122. Sdefine Latest Developments
Table 123. Pengbo Biotechnology Basic Information, Betaine for Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 124. Pengbo Biotechnology Betaine for Pharmaceutical Product Portfolios and Specifications
Table 125. Pengbo Biotechnology Betaine for Pharmaceutical Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Pengbo Biotechnology Main Business
Table 127. Pengbo Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Betaine for Pharmaceutical
Figure 2. Betaine for Pharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Betaine for Pharmaceutical Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Betaine for Pharmaceutical Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Betaine for Pharmaceutical Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Natural Betaine
Figure 10. Product Picture of Synthetic Betaine
Figure 11. Global Betaine for Pharmaceutical Sales Market Share by Type in 2022
Figure 12. Global Betaine for Pharmaceutical Revenue Market Share by Type (2018-2023)
Figure 13. Betaine for Pharmaceutical Consumed in Pharmaceutical
Figure 14. Global Betaine for Pharmaceutical Market: Pharmaceutical (2018-2023) & (Tons)
Figure 15. Betaine for Pharmaceutical Consumed in Dietary Supplements
Figure 16. Global Betaine for Pharmaceutical Market: Dietary Supplements (2018-2023) & (Tons)
Figure 17. Betaine for Pharmaceutical Consumed in Others
Figure 18. Global Betaine for Pharmaceutical Market: Others (2018-2023) & (Tons)
Figure 19. Global Betaine for Pharmaceutical Sales Market Share by Application (2022)
Figure 20. Global Betaine for Pharmaceutical Revenue Market Share by Application in 2022
Figure 21. Betaine for Pharmaceutical Sales Market by Company in 2022 (Tons)
Figure 22. Global Betaine for Pharmaceutical Sales Market Share by Company in 2022
Figure 23. Betaine for Pharmaceutical Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Betaine for Pharmaceutical Revenue Market Share by Company in 2022
Figure 25. Global Betaine for Pharmaceutical Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Betaine for Pharmaceutical Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Betaine for Pharmaceutical Sales 2018-2023 (Tons)
Figure 28. Americas Betaine for Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 29. APAC Betaine for Pharmaceutical Sales 2018-2023 (Tons)
Figure 30. APAC Betaine for Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 31. Europe Betaine for Pharmaceutical Sales 2018-2023 (Tons)
Figure 32. Europe Betaine for Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Betaine for Pharmaceutical Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Betaine for Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 35. Americas Betaine for Pharmaceutical Sales Market Share by Country in 2022
Figure 36. Americas Betaine for Pharmaceutical Revenue Market Share by Country in 2022
Figure 37. Americas Betaine for Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 38. Americas Betaine for Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 39. United States Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Betaine for Pharmaceutical Sales Market Share by Region in 2022
Figure 44. APAC Betaine for Pharmaceutical Revenue Market Share by Regions in 2022
Figure 45. APAC Betaine for Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 46. APAC Betaine for Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 47. China Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Betaine for Pharmaceutical Sales Market Share by Country in 2022
Figure 55. Europe Betaine for Pharmaceutical Revenue Market Share by Country in 2022
Figure 56. Europe Betaine for Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 57. Europe Betaine for Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 58. Germany Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Betaine for Pharmaceutical Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Betaine for Pharmaceutical Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Betaine for Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Betaine for Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 67. Egypt Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Betaine for Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Betaine for Pharmaceutical in 2022
Figure 73. Manufacturing Process Analysis of Betaine for Pharmaceutical
Figure 74. Industry Chain Structure of Betaine for Pharmaceutical
Figure 75. Channels of Distribution
Figure 76. Global Betaine for Pharmaceutical Sales Market Forecast by Region (2024-2029)
Figure 77. Global Betaine for Pharmaceutical Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Betaine for Pharmaceutical Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Betaine for Pharmaceutical Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Betaine for Pharmaceutical Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Betaine for Pharmaceutical Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の医薬品用ベタイン市場予測 2023年-2029年(Global Betaine for Pharmaceutical Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の化粧品用ベタイン市場予測 2023年-2029年
  • オレアミドプロピルベタインの世界市場見通し2023年-2029年
  • ベタインの世界市場展望（2022～2030）

    • ◆H&Iグローバルリサーチのお客様（例）◆